IDH1 and IDH2 (isocitrate dehydrogenase 1 and 2) are citric acid cycle enzymes that are recurrently affected by disease driving-mutations in myeloid malignancies, particularly AML (8% and 9% of cases, respectively) [2, 3, 19]. Here, IDH1 is linked to acute myeloid leukemia.